Monoclonal antibody specifically bound to CAV (canine adenovirus), pharmaceutical composition, kit and application of kit

A monoclonal antibody, canine adenovirus technology, applied in the direction of antiviral agents, antibodies, antiviral immunoglobulins, etc., can solve the problems of mass infection, high price, low sensitivity, etc., and achieve the effect of avoiding missed detection

Active Publication Date: 2019-01-18
LUOYANG PULIKE WANTAI BIOTECH
View PDF7 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current commercialized CAV colloidal gold test strips are expensive and have low sensitivity, resulting in fals...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody specifically bound to CAV (canine adenovirus), pharmaceutical composition, kit and application of kit
  • Monoclonal antibody specifically bound to CAV (canine adenovirus), pharmaceutical composition, kit and application of kit
  • Monoclonal antibody specifically bound to CAV (canine adenovirus), pharmaceutical composition, kit and application of kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0027] As an embodiment of the present invention, the antibody is a monoclonal antibody and a genetically engineered antibody; wherein, the genetically engineered antibody includes a single-chain antibody, a chimeric monoclonal antibody, a modified monoclonal antibody, and a canine monoclonal antibody or a fragment of said antibody; said antibody or said fragment of said antibody still retains the ability to specifically bind canine adenovirus.

[0028] As an embodiment of the present invention, the antibody is a monoclonal antibody 1A1, the amino acid sequence of the heavy chain variable region of the monoclonal antibody 1A1 is the amino acid sequence shown in SEQ.ID No.2, and its light chain variable region is The amino acid sequence is the amino acid sequence shown in SEQ.ID No.4.

[0029] Said monoclonal antibody 1A1, the amino acid sequence of the heavy chain variable region is SEQ.ID No.2, and the amino acid sequence of the light chain variable region is SEQ.ID No.4; the...

Embodiment 1

[0062] Embodiment 1 Existing product detection clinical sample result analysis

[0063] The collected 193 samples of clinical dog and fox disease were tested by Century Yuanheng CAV PCR Detection Kit according to the instructions, and 124 samples were found to be positive, including 95 samples positive for CAV-1 and 29 samples for CAV-2, and 69 samples were negative. South Korea Anjie CAV-CDV colloidal gold test strips and American Aibo CAV colloidal gold detection test strips were tested according to the instructions of their respective kits. The results are shown in Table 6. It was found that the positive coincidence rate between commercial test strips and PCR was only 12% to 19%, and the total coincidence rate was only 44% to 48%. It relaxes vigilance and cannot be prevented and treated early. Through follow-up investigations, it was found that dogs and foxes with missed tests and false negatives were subsequently infected more seriously and became ill, and their excrement...

Embodiment 2

[0064] Example 2 Preparation, Purification, Identification and Testing of Canine Adenovirus Monoclonal Antibody

[0065] 2.1 Preparation and purification of canine adenovirus monoclonal antibody

[0066] Cultivate canine adenovirus and purify the virus according to the method in Ma Zhiyong et al. Emulsified with adjuvant, and immunized mice with a final content of 200 μg / ml. After the fourth immunization, the mice were subjected to cell fusion. Using the HI method (the CAV-1 Utrecht strain and the CAV-2 Toronto A26 / 61 strain purchased from ATCC were used for human "O" red blood cells according to the "Chinese Veterinary Pharmacopoeia" 2015 edition, and the HA test was used to prepare 8 units of antigen according to the results. Afterwards, the samples to be tested were subjected to hemagglutination inhibition test (HI titer detection, according to the "Chinese Veterinary Pharmacopoeia" 2015 edition) for subcloning screening, and 10 positive hybridoma cells were obtained. At ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Sensitivityaaaaaaaaaa
Login to view more

Abstract

The invention provides a variable region sequence of a mouse monoclonal antibody specifically bound to a CAV (canine adenovirus) and an antibody specifically bound to the CAV. The antibody can be usedfor preparing a kit and pharmaceutical composition. According to the kit, the problem of low detection sensitivity in the prior art is solved, leak detection and false negative are avoided, various targets can be detected, and the kit has the advantages of being rapid, simple and accurate; the pharmaceutical composition can effectively prevent and treat disease caused by CAV-1 and CAV-2.

Description

technical field [0001] The invention relates to a canine adenovirus monoclonal antibody, a pharmaceutical composition prepared by using the monoclonal antibody, a kit and an application thereof, and belongs to the field of biotechnology. Background technique [0002] Canine adenovirus (Caine adenovirus, CAV) is the most pathogenic virus in the mammalian adenovirus genus, including two serotypes, namely canine adenovirus type I (CAV-1) and canine adenovirus type I (CAV-1). Virus type 2 (Canine adenovirus type II, CAV-2), in which CAV-1 mainly causes canine infectious hepatitis and encephalitis of bears and foxes, and CAV-2 mainly causes canine infectious laryngotracheitis and puppy pneumonia. Canine adenovirus disease is distributed globally, and dogs of different breeds, ages and sexes can be infected, and can occur throughout the year, with the highest infection rate and mortality rate (up to 25%) in puppies that have just been weaned to less than one year old. ~40%), the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/08G01N33/577G01N33/569G01N33/558A61K39/42A61P31/20
CPCC07K16/081G01N33/558G01N33/56983G01N33/577G01N2333/075
Inventor 田克恭王莹郝丽影
Owner LUOYANG PULIKE WANTAI BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap